Lexicon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $1,647 | $1,130 | $702 | $162 |
Gross Profit | 1,342 | 955 | 485 | 155 |
EBITDA | -55,215 | -45,189 | -46,590 | -46,626 |
EBIT | -55,354 | -45,333 | -46,737 | -46,777 |
Net Income | -53,429 | -48,397 | -48,244 | -50,525 |
Net Change In Cash | 1,647 | 1,130 | 702 | 162 |
Free Cash Flow | -48,790 | -55,130 | -50,548 | -41,702 |
Cash | 35,617 | 96,494 | 22,465 | 21,116 |
Basic Shares | 310,836 | 245,390 | 244,925 | 244,925 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,204 | $139 | $298 | $23,995 |
Gross Profit | 565 | -288 | -54,748 | 22,066 |
EBITDA | -171,196 | -99,164 | -86,956 | -176,018 |
EBIT | -171,750 | -99,591 | -87,248 | -178,952 |
Net Income | -177,119 | -103,128 | -88,268 | -70,184 |
Net Change In Cash | 1,204 | 139 | 298 | 23,995 |
Cost of Revenue | -17,720 | -62,198 | 90,151 | |
Free Cash Flow | -162,367 | -90,177 | -88,238 | -143,056 |
Cash | 22,465 | 46,345 | 64,065 | 126,263 |
Basic Shares | 221,130 | 165,733 | 145,652 | 110,841 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.17 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.20 |
2023-09-30 | -$0.21 |
